The causal relationship between HIV and AIDS was established in the mid-1980s. In 2008, French researchers won a Nobel Prize ...
With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.
A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...
The Michigan Department of Health and Human Services released its plan to reduce new HIV infections by 90% by 2030 on Monday.
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.
Argentines living with HIV/AIDS and medics say spending cuts under libertarian President Javier Milei are hurting treatment ...
As residents come together to recognize World AIDS Day, experts say early detection and modern drug regimens could eventually ...
President Museveni has reiterated his call to Ugandans to prevent themselves from getting infected with HIV/AIDS.
Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector’s efforts to fight the HIV epidemic in the ...